Following review of the data submitted, the Committee for Medicinal Products for Human Use (CHMP) requested the company to submit additional safety and efficacy data.
NovoSeven skulle have været anvendt til at behandle voksne patienter med intracerebral hæmorrhagi (blødning inde i hjernen).